NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 209 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR How the National Cancer Act Has Made a Difference in Cancer... February 18, 2021 OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally... August 4, 2025 New Generation of Antibody-Drug Conjugates (ADCs) Shows Unprecedented Promise in Early-Stage... October 18, 2025 DIY Mosquito Traps & Deterrents (That Really Work) June 23, 2021 Load more HOT NEWS TRACERx EVO, a new programme to transform lung cancer research FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for... Woman Diagnosed with Cancer a Week After Her Honeymoon Helps Others... Our new strategy to make discoveries, drive progress, and bring hope
